Search

Author/Creator Fakih, Marwan

42. TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first‐line treatment of metastatic colorectal cancer. Issue 24 (1st October 2013)

Authors:
Fuchs, Charles S.; Fakih, Marwan; Schwartzberg, Lee; Cohn, Allen L.; Yee, Lorrin; Dreisbach, Luke; Kozloff, Mark F.; Hei, Yong‐jiang; Galimi, Francesco; Pan, Yang; Haddad, Vincent; Hsu, Cheng‐Pang; Sabin, Antony; Saltz, Leonard
Journal:
Cancer
Issue:
Volume 119:Issue 24(2013)
Page Start:
4290
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

43. TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first‐line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trial. Issue 24 (1st October 2013)

Authors:
Fuchs, Charles S.; Fakih, Marwan; Schwartzberg, Lee; Cohn, Allen L.; Yee, Lorrin; Dreisbach, Luke; Kozloff, Mark F.; Hei, Yong‐jiang; Galimi, Francesco; Pan, Yang; Haddad, Vincent; Hsu, Cheng‐Pang; Sabin, Antony; Saltz, Leonard
Journal:
Cancer
Issue:
Volume 119:Issue 24(2013)
Page Start:
4290
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

44. Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial. Issue 6 (June 2021)

Authors:
Siena, Salvatore; Di Bartolomeo, Maria; Raghav, Kanwal; Masuishi, Toshiki; Loupakis, Fotios; Kawakami, Hisato; Yamaguchi, Kensei; Nishina, Tomohiro; Fakih, Marwan; Elez, Elena; Rodriguez, Javier; Ciardiello, Fortunato; Komatsu, Yoshito; Esaki, Taito; Chung, Ki; Wainberg, Zev; Sartore-Bianchi, And...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 6(2021)
Page Start:
779
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗